irbesartan-mepha 300 mg compresse rivestite con film
mepha pharma ag - irbesartanum - compresse rivestite con film - irbesartanum 300.0 mg, povidonum k 30, amylum pregelificatum, poloxamerum 188, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 1.29 mg, silica colloidalis hydrica, magnesii stearas, Überzug: polydextrosum, e 171, hypromellosum, macrogolum 4000, pro compresso obducto. - antihypertensivum - synthetika
nasacort allergo spray nasale
opella healthcare switzerland ag - triamcinoloni acetonidum - spray nasale - triamcinoloni acetonidum 0.55 mg/ml corresp. 55 µg pro dosi, dinatrii edetas, glucosum, cellulosum microcristallinum, carmellosum natricum, polysorbatum 80, acidum hydrochloricum q.s. ad ph, natrii hydroxidum q.s. ad ph, benzalkonii chloridum 0.15 mg, aqua purificata ad suspensionem pro 1 ml, doses pro vase 30. - saisonale allergische rhinitis bei erwachsenen - synthetika
co-amoxicillin devatis 625 mg compresse rivestite con film
devatis ag - amoxicillinum anhydricum, acido clavulanicum - compresse rivestite con film - amoxicillinum anhydricum 500 mg ut amoxicillinum trihydricum, acidum clavulanicum 125 mg ut kalii clavulanas, carmellosum natricum conexum corresp. natrium 1.142 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, polydextrosum, copovidonum, triglycerida media, e 171, pro compresso obducto. - malattie infettive - synthetika
co-amoxicillin devatis 1 g compresse rivestite con film
devatis ag - amoxicillinum anhydricum, acido clavulanicum - compresse rivestite con film - amoxicillinum anhydricum 875 mg ut amoxicillinum trihydricum, acidum clavulanicum 125 mg ut kalii clavulanas, carmellosum natricum conexum corresp. natrium 1.696 mg, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, polydextrosum, copovidonum, triglycerida media, e 171, pro compresso obducto. - malattie infettive - synthetika
truqap 160 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 160 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 1.82 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
truqap 200 mg compresse rivestite con film
astrazeneca ag - capivasertibum - compresse rivestite con film - capivasertibum 200 mg, cellulosum microcristallinum, calcii hydrogenophosphas, carmellosum natricum conexum corresp. natrium max. 2.28 mg, magnesii stearas, Überzug: hypromellosum, copovidonum k 28, macrogolum 3350, polydextrosum, triglycerida media, e 171, e 172 (flavum), e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - carcinoma della mammella - synthetika
mutaflor capsule
om pharma suisse sa - escherichia coli viva (souche: nissle 1917) - capsule - escherichia coli viva (souche: nissle 1917) 2.5-25 u. mia, maltodextrinum, glycerolum 3.09-15.47 mg, talco, macrogolum 4000, triethylis citras, acidi methacrylici e methylis methacrylatis polymerisatum 1:1, lacca, cera bianca, cera carnauba, e 171, e 172 (giallo), per la capsula, matériel de la capsula: gelatina, acqua purificata. - la colite ulcerosa in fase di remissione - batteri e hefepräparate
mutaflor mite capsule
om pharma suisse sa - escherichia coli viva (souche: nissle 1917) - capsule - escherichia coli viva (souche: nissle 1917) 0.5-5 u. mia, maltodextrinum, glycerolum 1.24-6.19 mg, talco, macrogolum 4000, triethylis citras, acidi methacrylici e methylis methacrylatis polymerisatum 1:1, lacca, cera bianca, cera carnauba, e 171, e 172 (giallo), per la capsula, matériel de la capsula: gelatina, acqua purificata. - la colite ulcerosa in fase di remissione - batteri e hefepräparate
dukoral suspension und brausegranulat zur herstellung einer suspension zum einnehmen
bavarian nordic switzerland ag - vibrio cholerae o1 inaba 6973 biotipus el tor inactivatus (formaldehydum), vibrio cholerae o1 inaba 48 classical biotyp inactivatus (calor), vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (calor), vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (formaldehydum), toxinum cholerae subunitatis b recombinatum (rctb-213) - suspension und brausegranulat zur herstellung einer suspension zum einnehmen - vaccinum attenuatum per os: vibrio cholerae o1 inaba 6973 biotipus el tor inactivatus (formaldehydum) 31.25 mia. u., vibrio cholerae o1 inaba 48 classical biotyp inactivatus (calor) 31.25 mia. u., vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (calor) 31.25 mia. u., vibrio cholerae o1 ogawa 50 classical biotyp inactivatus (formaldehydum) 31.25 mia. u., toxinum cholerae subunitatis b recombinatum (rctb-213) 1 mg, natrii chloridum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, aqua ad iniectabile, q.s. ad suspensionem pro 3 ml. granulat: natrii hydrogenocarbonas, acidum citricum, aromatica cum maltodextrinum, saccharinum natricum, natrii carbonas, natrii citras dihydricus, ad granulatum pro 5.6 g. suspensio reconstituta: suspensio reconstituta corresp. natrium ca. 1.2 g. - aktive immunisierung gegen cholera und etec-diarrhoe ab dem 2. geburtstag - vaccini
dulcolax bisacodyl magensaftresitente tabletten
opella healthcare switzerland ag - bisacodylum - magensaftresitente tabletten - bisacodylum 5 mg, lactosum monohydricum 34.9 mg, maydis amylum, amylodextrinum, glycerolum (85 per centum), magnesii stearas, Überzug: magnesii stearas, saccharum 23.3819 mg, talcum, acaciae gummi, e 171, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, ricini oleum virginale, macrogolum 6000, e 172 (flavum), cera alba, cera carnauba, lacca, pro compresso obducto. - laxans - synthetika